The company's technical setup has turned constructive — golden-cross formation, rising volume accumulation, RSI at 57, three beats in the last four quarters — yet revenue has been contracting approximately 4% year-over-year, the business lacks a competitive moat, and the reward-to-risk ratio is below 1-to-1 at current prices, making the setup unattractive for new buyers even as near-term price momentum improves.
Thesis pillars
- Momentum Breakout Thin Upside↑Improving
- Revenue Contraction Challenges Recovery→Stable
- Exceptional Cash Conversion No Moat→Stable
- +1 more pillar — see the Why tab for full reasoning
Pillars as of Jul 3, 2026, based on the 10-K filed Feb 27, 2026· older than 90 days
International Flavors & Fragran (IFF) Stock Analysis
Breakout setup
Basic Materials · Specialty Chemicals
Sell if holding. Engine safety override at $92.18: Quality below floor (3.4 < 4.0) triggers a hard block regardless of the otherwise-positive setup — overall score 4.4/10. Specifically: Below-average business quality.
International Flavors & Fragrances creates and manufactures flavors, food ingredients, enzymes, cultures, and fragrance compounds sold to food, beverage, personal care, and health product manufacturers worldwide. The company reported $10.890 billion in 2025 sales across four... Read more
Sell if holding. Engine safety override at $92.18: Quality below floor (3.4 < 4.0) triggers a hard block regardless of the otherwise-positive setup — overall score 4.4/10. Specifically: Below-average business quality. Chart setup: Golden cross, above all MAs, RSI 59, MACD bullish. Score 4.4/10, moderate confidence.
Passes 6/7 gates (positive momentum, clean insider activity, no SEC red flags, earnings proximity no date, semi cycle peak clear, materials cycle peak clear). Fails on favorable risk/reward ratio. Suitability: moderate.
Recent developments
updated Nov 3, 2026Recent Developments — International Flavors & Fragran
Latest news
- NEWS International Flavors & Fragrances Inc. Reports Q3 2026 Financial Results — fiscal.ai Nov 3, 2026 neutral
- NEWS Intl Flavors & Fragrances Raises FY2026 Sales Guidance from $7.400B-$7.600B to $7.500B-$7.600B vs $7.594B Est — benzinga Nov 3, 2026 positive
- NEWS Intl Flavors & Fragrances Q3 Adj. EPS $0.83 Beats $0.80 Estimate, Sales $1.942B Beat $1.908B Estimate — benzinga Nov 3, 2026 neutral
- NEWS AMD, Shopify On Deck Tuesday As AI Spending, Merchant Growth Face Test — benzinga Nov 2, 2026 neutral
- NEWS Ralf Finzel Departs IFF for Leadership Role at ADM — fiscal.ai Nov 2, 2026 negative
Latest item Nov 3, 2026 · Generated 2026-11-04T12:10:03Z.
Upcoming dated catalysts
Thesis
Key Metrics
Quality Signals
Options Flow
Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results. How we score · Editorial policy
Show full disclosure ▾Hide full disclosure ▴
About TrendMatrix. TrendMatrix is a publisher of general securities research and market commentary. We publish on a regular schedule. All content is the same for every subscriber in a tier — we do not provide personalized investment advice and we do not take into account any individual subscriber's financial situation, investment objectives, risk tolerance, tax situation, or holdings.
Not investment advice. TrendMatrix is not a registered investment adviser. Our content is for informational and educational purposes only. Consult your own licensed investment adviser, broker, or tax professional before making any investment decision.
Conflicts and positions. People who build TrendMatrix, or entities they control, may hold positions, long or short, in securities it covers, and may trade them at any time. Positions are not disclosed individually. Verdicts are generated by an automated model applied by the same rules to every covered stock, and are not adjusted for any position held by the people who build TrendMatrix. We do not accept payment from issuers for coverage.
No paid promotion. TrendMatrix does not accept payment from any issuer, broker, or third party in exchange for coverage of any security.
No fiduciary duty. No fiduciary, advisory, or agency relationship is created between you and TrendMatrix by reading our content or subscribing to our service.
Performance. Past performance is not indicative of future results. Performance figures reflect the published model only and do not reflect any individual subscriber's actual results.
Rating Breakdown
4 floor-breakers
Growth below the gate floor. Component breakdown shows what dragged the score down.static
Ranks in the bottom of its industry peers on the composite signal. Better names in the same sector exist.static
Quality below the gate floor. Component breakdown shows what dragged the score down.static
No near-term catalyst priced in. Thesis progression will come from fundamentals grinding, not event reaction.static
Price Targets
Position Sizing
Risk Alerts
Earnings
Verdict History
Frequently Asked Questions
Sell if holding. Engine safety override at $92.18: Quality below floor (3.4 < 4.0) triggers a hard block regardless of the otherwise-positive setup — overall score 4.4/10. Specifically: Below-average business quality. Chart setup: Golden cross, above all MAs, RSI 59, MACD bullish. Prior stop was $88.00. Score 4.4/10, moderate confidence.
Analyst target $87.72 reached (−4.8% from $92.18); no take-profit level is published. Prior stop was $88.00. Stop-loss: $88.00.
Target reached (-4.8% upside); Quality below floor (3.4 < 4.0).
International Flavors & Fragran trades at a P/E of 263.4 (forward 23.5). TrendMatrix value score: 5.0/10. Verdict: Sell.
25 analysts rate IFF, with a consensus score of 4.0/5. 17 analysts publish price targets averaging $97.
What does International Flavors & Fragran do?International Flavors & Fragrances creates and manufactures flavors, food ingredients, enzymes, cultures, and fragrance...
International Flavors & Fragrances creates and manufactures flavors, food ingredients, enzymes, cultures, and fragrance compounds sold to food, beverage, personal care, and health product manufacturers worldwide. The company reported $10.890 billion in 2025 sales across four segments after divesting Pharma Solutions in May 2025, with 28% from the U.S. and no single customer exceeding 10% of sales; approximately 21,500 employees operate across 170 facilities in 30 countries.